These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 21749385)

  • 1. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies.
    Li C; Cui J; Wang C; Zhang L; Xiu X; Li Y; Wei N; Li Y; Zhang L
    J Pharm Pharmacol; 2011 Mar; 63(3):376-84. PubMed ID: 21749385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of pegylated liposomal vinorelbine formulation using "post-insertion" technology.
    Li CL; Cui JX; Wang CX; Zhang L; Li YH; Zhang L; Xiu X; Li YF; Wei N
    Int J Pharm; 2010 May; 391(1-2):230-6. PubMed ID: 20214962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
    Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
    J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of interfacial cholesterol-anchored polyethylene glycol on sterol-rich non-phospholipid liposomes.
    Cui ZK; Edwards K; Nieto Orellana A; Bastiat G; Benoit JP; Lafleur M
    J Colloid Interface Sci; 2014 Aug; 428():111-20. PubMed ID: 24910042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
    Dadashzadeh S; Vali AM; Rezaie M
    Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
    Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
    J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator.
    Kim JY; Kim JK; Park JS; Byun Y; Kim CK
    Biomaterials; 2009 Oct; 30(29):5751-6. PubMed ID: 19656559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel sulfobutyl ether cyclodextrin gradient leads to highly active liposomal irinotecan formulation.
    Li C; Cui J; Wang C; Li Y; Zhang L; Xiu X; Li Y; Wei N; Zhang L; Wang P
    J Pharm Pharmacol; 2011 Jun; 63(6):765-73. PubMed ID: 21585373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?
    Cui J; Li C; Wang C; Li Y; Zhang L; Zhang L; Xiu X; Li Y; Wei N
    J Pharm Sci; 2011 Jul; 100(7):2835-48. PubMed ID: 21305545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes.
    Hossann M; Syunyaeva Z; Schmidt R; Zengerle A; Eibl H; Issels RD; Lindner LH
    J Control Release; 2012 Sep; 162(2):400-6. PubMed ID: 22759980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfosalicylate mediates improved vinorelbine loading into LUVs and antineoplastic effects.
    Li C; Cui J; Wang C; Cao J; Zhang L; Li Y; Liang M; Xiu X; Li Y; Wei N; Deng C
    J Liposome Res; 2012 Mar; 22(1):42-54. PubMed ID: 21696260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity.
    Semple SC; Leone R; Wang J; Leng EC; Klimuk SK; Eisenhardt ML; Yuan ZN; Edwards K; Maurer N; Hope MJ; Cullis PR; Ahkong QF
    J Pharm Sci; 2005 May; 94(5):1024-38. PubMed ID: 15793796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid composition and grafted PEG affect in vivo activity of liposomal mitoxantrone.
    Li C; Cui J; Wang C; Wang J; Li Y; Zhang L; Zhang L; Guo W; Wang Y
    Int J Pharm; 2008 Oct; 362(1-2):60-6. PubMed ID: 18598745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro characterisation and biodistribution of some non-ionic surfactant coated liposomes in the rabbit.
    Khattab MA; Farr SJ; Taylor G; Kellaway IW
    J Drug Target; 1995; 3(1):39-49. PubMed ID: 7655819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method.
    Qiu L; Jing N; Jin Y
    Int J Pharm; 2008 Sep; 361(1-2):56-63. PubMed ID: 18573626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel liposomal gefitinib (L-GEF) formulations.
    Zhou X; Yung B; Huang Y; Li H; Hu X; Xiang G; Lee RJ
    Anticancer Res; 2012 Jul; 32(7):2919-23. PubMed ID: 22753756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention.
    Zhigaltsev IV; Maurer N; Akhong QF; Leone R; Leng E; Wang J; Semple SC; Cullis PR
    J Control Release; 2005 May; 104(1):103-11. PubMed ID: 15866338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of liposome encapsulation technique to improve anti-carcinoma effect of resveratrol.
    Lu XY; Hu S; Jin Y; Qiu LY
    Drug Dev Ind Pharm; 2012 Mar; 38(3):314-22. PubMed ID: 21851312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.